Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
about
The role of drug transporters in the kidney: lessons from tenofovirLapatinib antagonizes multidrug resistance-associated protein 1-mediated multidrug resistance by inhibiting its transport function.Quizartinib (AC220) reverses ABCG2-mediated multidrug resistance: In vitro and in vivo studies.Tyrosine kinase inhibitors enhanced the efficacy of conventional chemotherapeutic agent in multidrug resistant cancer cells.
P2860
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
@en
type
label
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
@en
prefLabel
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells.
@en
P2093
P2860
P356
P1433
P1476
Ponatinib enhances anticancer drug sensitivity in MRP7-overexpressing cells
@en
P2093
Kamlesh Sodani
Maria R Baer
Wen-Qi Jiang
Yihang Pan
Yue-Li Sun
Zhe-Sheng Chen
P2860
P304
P356
10.3892/OR.2014.3002
P577
2014-01-28T00:00:00Z